Invention Grant
US07947730B2 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor
失效
哌啶鎓和吡咯烷鎓衍生物作为毒蕈碱M3受体的配体
- Patent Title: Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor
- Patent Title (中): 哌啶鎓和吡咯烷鎓衍生物作为毒蕈碱M3受体的配体
-
Application No.: US10561366Application Date: 2004-06-23
-
Publication No.: US07947730B2Publication Date: 2011-05-24
- Inventor: Stephen Paul Collingwood , Urs Baettig , Clive McCarthy
- Applicant: Stephen Paul Collingwood , Urs Baettig , Clive McCarthy
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Cozette M McAvoy
- Priority: GB0314697.4 20030624; GB0327526.0 20031126
- International Application: PCT/EP2004/006795 WO 20040623
- International Announcement: WO2005/000815 WO 20050106
- Main IPC: A61K31/40
- IPC: A61K31/40 ; C07D409/14
Abstract:
Compounds of formula I in salt or zwitterionic form wherein, wherein R1, R2, R3, R4, R5, J, L and M have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the muscarinic M3 receptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
Public/Granted literature
- US20060287362A1 Organic compounds Public/Granted day:2006-12-21
Information query
